GLP-1 agonists including semaglutide slow gastric emptying, which can intensify alcohol effects and increase nausea risk
J Toxicol Environ Health Part B 13(5):385
The TRIUMPH clinical trial program is evaluating retatrutide for multiple indications beyond simple weight loss, including obesity with osteoarthritis, obesity with metabolic complications, type 2 diabetes, cardiovascular outcomes, obstructive sleep apnea, and metabolic dysfunction-associated steatohepatitis
Fitness Boost IV Drip Benefits Metabolic support Appetite control Detoxification support Who should take it
Thymalin, another peptide with immune-supporting properties, may complement epithalon's cellular effects when administered in coordinated protocols
Many women will never need GLP-1s